195 related articles for article (PubMed ID: 33389516)
1. Serum uromodulin levels, MR imaging findings, and their relationship with eGFR-based CKD staging in ADPKD patients.
Cansever HN; Sari F; Cevikol C; Cetinkaya R; Süleymanlar G; Ersoy F
Int Urol Nephrol; 2021 Jul; 53(7):1383-1389. PubMed ID: 33389516
[TBL] [Abstract][Full Text] [Related]
2. The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease.
Coban M; Inci A
Int Urol Nephrol; 2018 Jul; 50(7):1293-1300. PubMed ID: 29654395
[TBL] [Abstract][Full Text] [Related]
3. Correlation of serum galectin-3 level with renal volume and function in adult polycystic kidney disease.
Ozkurt S; Dogan I; Ozcan O; Fidan N; Bozaci I; Yilmaz B; Bilgin M
Int Urol Nephrol; 2019 Jul; 51(7):1191-1197. PubMed ID: 31012038
[TBL] [Abstract][Full Text] [Related]
4. Plasma Uromodulin Correlates With Kidney Function and Identifies Early Stages in Chronic Kidney Disease Patients.
Steubl D; Block M; Herbst V; Nockher WA; Schlumberger W; Satanovskij R; Angermann S; Hasenau AL; Stecher L; Heemann U; Renders L; Scherberich J
Medicine (Baltimore); 2016 Mar; 95(10):e3011. PubMed ID: 26962815
[TBL] [Abstract][Full Text] [Related]
5. Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease.
Kline TL; Korfiatis P; Edwards ME; Bae KT; Yu A; Chapman AB; Mrug M; Grantham JJ; Landsittel D; Bennett WM; King BF; Harris PC; Torres VE; Erickson BJ;
Kidney Int; 2017 Nov; 92(5):1206-1216. PubMed ID: 28532709
[TBL] [Abstract][Full Text] [Related]
6. Serum uromodulin concentrations correlate with glomerular filtration rate in patients with chronic kidney disease.
Fedak D; Kuźniewski M; Fugiel A; Wieczorek-Surdacka E; Przepiórkowska-Hoyer B; Jasik P; Miarka P; Dumnicka P; Kapusta M; Solnica B; Sułowicz W
Pol Arch Med Wewn; 2016 Dec; 126(12):995-1004. PubMed ID: 27958261
[TBL] [Abstract][Full Text] [Related]
7. The association of endothelin-1 levels with renal survival in polycystic kidney disease patients.
Kocyigit I; Eroglu E; Kaynar AS; Kocer D; Kargi S; Zararsiz G; Bayramov R; Imamoglu H; Sipahioglu MH; Tokgoz B; Dundar M; Oymak O
J Nephrol; 2019 Feb; 32(1):83-91. PubMed ID: 30022320
[TBL] [Abstract][Full Text] [Related]
8. Kidney volume and function in autosomal dominant polycystic kidney disease.
Higashihara E; Nutahara K; Okegawa T; Shishido T; Tanbo M; Kobayasi K; Nitadori T
Clin Exp Nephrol; 2014 Feb; 18(1):157-65. PubMed ID: 23864346
[TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional study.
Miskulin DC; Abebe KZ; Chapman AB; Perrone RD; Steinman TI; Torres VE; Bae KT; Braun W; Winklhofer FT; Hogan MC; Rahbari-Oskoui F; Moore CG; Flessner MF; Schrier RW;
Am J Kidney Dis; 2014 Feb; 63(2):214-26. PubMed ID: 24183837
[TBL] [Abstract][Full Text] [Related]
10. Tolvaptan in Japanese patients with later-stage autosomal dominant polycystic kidney disease.
Oguro M; Kogure Y; Hoshino J; Ubara Y; Mizuno H; Sekine A; Kawada M; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Takaichi K
J Nephrol; 2018 Dec; 31(6):961-966. PubMed ID: 30357715
[TBL] [Abstract][Full Text] [Related]
11. Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease.
Yu ASL; Shen C; Landsittel DP; Harris PC; Torres VE; Mrug M; Bae KT; Grantham JJ; Rahbari-Oskoui FF; Flessner MF; Bennett WM; Chapman AB;
Kidney Int; 2018 Mar; 93(3):691-699. PubMed ID: 29290310
[TBL] [Abstract][Full Text] [Related]
12. Serum uromodulin is a novel renal function marker in the Japanese population.
Usui R; Ogawa T; Takahashi H; Iwasaki C; Koike M; Morito T; Hatano M; Nitta K
Clin Exp Nephrol; 2021 Jan; 25(1):28-36. PubMed ID: 32915368
[TBL] [Abstract][Full Text] [Related]
13. Soluble klotho and autosomal dominant polycystic kidney disease.
Pavik I; Jaeger P; Ebner L; Poster D; Krauer F; Kistler AD; Rentsch K; Andreisek G; Wagner CA; Devuyst O; Wüthrich RP; Schmid C; Serra AL
Clin J Am Soc Nephrol; 2012 Feb; 7(2):248-57. PubMed ID: 22193235
[TBL] [Abstract][Full Text] [Related]
14. Plasma metabolites and lipids associate with kidney function and kidney volume in hypertensive ADPKD patients early in the disease course.
Kim K; Trott JF; Gao G; Chapman A; Weiss RH
BMC Nephrol; 2019 Feb; 20(1):66. PubMed ID: 30803434
[TBL] [Abstract][Full Text] [Related]
15. The value of uromodulin as a new serum marker to predict decline in renal function.
Leiherer A; Muendlein A; Saely CH; Brandtner EM; Geiger K; Fraunberger P; Drexel H
J Hypertens; 2018 Jan; 36(1):110-118. PubMed ID: 28858977
[TBL] [Abstract][Full Text] [Related]
16. Hemorrhagic Cysts and Other MR Biomarkers for Predicting Renal Dysfunction Progression in Autosomal Dominant Polycystic Kidney Disease.
Riyahi S; Dev H; Blumenfeld JD; Rennert H; Yin X; Attari H; Barash I; Chicos I; Bobb W; Donahue S; Prince MR
J Magn Reson Imaging; 2021 Feb; 53(2):564-576. PubMed ID: 32969110
[TBL] [Abstract][Full Text] [Related]
17. The correlation between kidney volume and measured glomerular filtration rate in an Asian ADPKD population: a prospective cohort study.
Phakdeekitcharoen B; Treesinchai W; Wibulpolprasert P; Boongird S; Klytrayong P
BMC Nephrol; 2021 May; 22(1):178. PubMed ID: 33992075
[TBL] [Abstract][Full Text] [Related]
18. Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease.
Park HC; Kim J; Cho A; Kim DH; Lee YK; Ryu H; Kim H; Oh KH; Oh YK; Hwang YH; Lee KB; Kim SW; Kim YH; Lee J; Ahn C;
J Korean Med Sci; 2020 Jun; 35(22):e165. PubMed ID: 32508065
[TBL] [Abstract][Full Text] [Related]
19. Increased urinary Angiotensinogen/Creatinine (AGT/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients.
Park HC; Kang AY; Jang JY; Kim H; Han M; Oh KH; Kim SH; Noh JW; Cheong HI; Hwang YH; Ahn C
BMC Nephrol; 2015 Jun; 16():86. PubMed ID: 26092580
[TBL] [Abstract][Full Text] [Related]
20. Cystatin C estimated glomerular filtration rate to assess renal function in early stages of autosomal dominant polycystic kidney disease.
Sans L; Radosevic A; Quintian C; Montañés R; Gràcia S; Vilaplana C; Mojal S; Ballarin JA; Fernández-Llama P; Torra R; Pascual J
PLoS One; 2017; 12(3):e0174583. PubMed ID: 28346513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
